Alexander Roediger

443 total citations
22 papers, 203 citations indexed

About

Alexander Roediger is a scholar working on Economics and Econometrics, General Health Professions and Oncology. According to data from OpenAlex, Alexander Roediger has authored 22 papers receiving a total of 203 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Economics and Econometrics, 5 papers in General Health Professions and 4 papers in Oncology. Recurrent topics in Alexander Roediger's work include Health Systems, Economic Evaluations, Quality of Life (15 papers), Economic and Financial Impacts of Cancer (10 papers) and Pharmaceutical Economics and Policy (10 papers). Alexander Roediger is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (15 papers), Economic and Financial Impacts of Cancer (10 papers) and Pharmaceutical Economics and Policy (10 papers). Alexander Roediger collaborates with scholars based in United Kingdom, United States and Switzerland. Alexander Roediger's co-authors include Lydia Makaroff, Kristine Sørensen, Christoph Zielinski, Anna Bucsics, Nils Wilking, Gisela Kobelt, Lidija Kandolf Sekulović, Thomas D. Szucs, Andrea Laslop and Geoffrey Henning and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Oncology and Value in Health.

In The Last Decade

Alexander Roediger

20 papers receiving 200 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alexander Roediger United Kingdom 8 84 60 38 38 34 22 203
Kavitha Rajsekar India 10 120 1.4× 30 0.5× 62 1.6× 19 0.5× 14 0.4× 28 271
Karlijn de Joode Netherlands 5 34 0.4× 163 2.7× 15 0.4× 32 0.8× 15 0.4× 23 203
Jordan P. McPherson United States 10 23 0.3× 92 1.5× 25 0.7× 13 0.3× 22 0.6× 24 187
Gabriela Sousa Portugal 8 32 0.4× 71 1.2× 10 0.3× 36 0.9× 16 0.5× 35 163
Marina Amaral de Ávila Machado Brazil 10 51 0.6× 21 0.3× 16 0.4× 16 0.4× 88 2.6× 23 408
Peter Sankey United Kingdom 5 53 0.6× 230 3.8× 41 1.1× 55 1.4× 11 0.3× 9 252
Abdullah A. Alsharm Saudi Arabia 6 50 0.6× 209 3.5× 41 1.1× 46 1.2× 6 0.2× 18 307
Katelijne van de Vooren Italy 8 121 1.4× 23 0.4× 18 0.5× 8 0.2× 33 1.0× 14 190
Gilberto Morgan Sweden 10 39 0.5× 177 3.0× 124 3.3× 37 1.0× 30 0.9× 32 317
Kirsten Sloan United States 4 54 0.6× 160 2.7× 28 0.7× 32 0.8× 6 0.2× 4 268

Countries citing papers authored by Alexander Roediger

Since Specialization
Citations

This map shows the geographic impact of Alexander Roediger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Roediger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Roediger more than expected).

Fields of papers citing papers by Alexander Roediger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander Roediger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Roediger. The network helps show where Alexander Roediger may publish in the future.

Co-authorship network of co-authors of Alexander Roediger

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander Roediger. A scholar is included among the top collaborators of Alexander Roediger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander Roediger. Alexander Roediger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Roediger, Alexander, et al.. (2025). Determining fair medicines prices. What do citizens think?. Health Policy and Technology. 15(1). 101126–101126.
3.
Roediger, Alexander, et al.. (2024). What is a fair price for a medicine? Establishing the main elements of a fair price based on the current policy debate. Public Health. 231. 148–153. 1 indexed citations
4.
Roediger, Alexander, et al.. (2023). Why is the screening rate in lung cancer still low? A seven-country analysis of the factors affecting adoption. Frontiers in Public Health. 11. 1264342–1264342. 19 indexed citations
5.
Costa, Luís, André Mansinho, Cláudia Vieira, et al.. (2023). Health outcomes and budget impact projection of anti-PD-(L)1s in cancer care in Portugal. Frontiers in Public Health. 11. 1133959–1133959. 2 indexed citations
6.
Roediger, Alexander, et al.. (2022). Should we screen for lung cancer? A 10-country analysis identifying key decision-making factors. Health Policy. 126(9). 879–888. 16 indexed citations
7.
Pistollato, Michele, et al.. (2021). PCN36 Oncology Combinations: How to Ensure Timely Access?. Value in Health. 24. S25–S25. 1 indexed citations
8.
Wilking, Nils, et al.. (2021). Budget projections and clinical impact of an immuno-oncology class of treatments: Experience in four EU markets. Journal of Cancer Policy. 28. 100279–100279. 7 indexed citations
9.
Hemelsoet, Dimitri, et al.. (2021). Accelerating patient access to oncology medicines with multiple indications in Europe. SHILAP Revista de lepidopterología. 9(1). 1964791–1964791. 13 indexed citations
10.
Pistollato, Michele, et al.. (2020). 1592P Happy wedding? Access and availability of oncology combination medicines. Annals of Oncology. 31. S963–S963. 1 indexed citations
11.
Sørensen, Kristine, et al.. (2020). The call for a strategic framework to improve cancer literacy in Europe. Archives of Public Health. 78(1). 60–60. 23 indexed citations
12.
Roediger, Alexander, et al.. (2019). Nothing about me without me: why an EU health literacy strategy embracing the role of citizens and patients is needed. Archives of Public Health. 77(1). 17–17. 7 indexed citations
13.
14.
Roediger, Alexander, et al.. (2019). Competition between on-patent medicines in Europe. Health Policy. 123(7). 652–660. 6 indexed citations
15.
Roediger, Alexander, et al.. (2019). PP39 Budget Projections And Health Impact Of PD-1/PD-L1 Inhibitors. International Journal of Technology Assessment in Health Care. 35(S1). 44–45. 1 indexed citations
16.
Roediger, Alexander, et al.. (2018). Assessing the impact of PD-1/PD-L1 inhibitors on health and budget in Belgium. European Journal of Public Health. 28(suppl_4). 1 indexed citations
17.
Aapro, Matti, Rachel Hess, Francesco De Lorenzo, et al.. (2017). All.Can initiative: improving efficiency in cancer care. Annals of Oncology. 28. v395–v395. 1 indexed citations
18.
Roediger, Alexander, et al.. (2017). What pricing and reimbursement policies to use for off-patent biologicals in Europe? – results from the second EBE biological medicines policy survey. Generics and Biosimilars Initiative Journal. 6(2). 61–78. 20 indexed citations
19.
Acha, Virginia, et al.. (2014). Tell me the whole story: the role of product labelling in building user confidence in biosimilars in Europe. Generics and Biosimilars Initiative Journal. 3(4). 188–192. 7 indexed citations
20.
Szucs, Thomas D., Mohammad A. Chaudhary, Ritesh Kumar, et al.. (2009). Cost-effectiveness of Raltegravir in Antiretroviral Treatment-Experienced HIV-1–Infected Patients in Switzerland. HIV Clinical Trials. 10(4). 233–253. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kavitha Rajsekar Breakdown of academic impact, for papers by Karlijn de Joode Breakdown of academic impact, for papers by Jordan P. McPherson Breakdown of academic impact, for papers by Gabriela Sousa Breakdown of academic impact, for papers by Marina Amaral de Ávila Machado Breakdown of academic impact, for papers by Peter Sankey Breakdown of academic impact, for papers by Abdullah A. Alsharm Breakdown of academic impact, for papers by Katelijne van de Vooren Breakdown of academic impact, for papers by Gilberto Morgan Breakdown of academic impact, for papers by Kirsten Sloan
Rankless by CCL
2026